Target Name: ZNF280C
NCBI ID: G55609
Review Report on ZNF280C Target / Biomarker Content of Review Report on ZNF280C Target / Biomarker
ZNF280C
Other Name(s): zinc finger protein 280C | zinc finger protein proximal to RAD eighteen | Zinc finger protein 280C | Suppressor of hairy wing homolog 3 | suppressor of hairy wing homolog 3 | SUHW3 | Zinc finger protein 633 | ZNF633 | Z280C_HUMAN | zinc finger protein 633 | ZPET

ZNF280C: A Potential Drug Target and Biomarker

Zinc finger proteins (ZFPs) are a family of non-coding RNAs that play a crucial role in gene regulation and are involved in various cellular processes. ZNF280C, a specific ZFP, has been identified as a potential drug target and biomarker in various diseases. In this article, we will explore the biology of ZNF280C, its potential drug targets, and its potential as a biomarker for various diseases.

Biography of ZNF280C

ZNF280C is a 280-basic-unit ZFP that contains a unique N-terminus, a characteristic feature of ZFPs. It has a single exon that encodes the protein sequence. ZNF280C is expressed in various tissues and cells, including brain, heart, liver, and pancreas, and is involved in various cellular processes, including cell growth, apoptosis, and inflammation.

Potential Drug Target

ZNF280C has been identified as a potential drug target due to its unique structure and its involvement in various cellular processes. One of its potential drug targets is the protein p53, which is a well-known tumor suppressor protein that plays a crucial role in preventing cancer growth.

ZNF280C has been shown to interact with p53 and can modulate its activity. This interaction between ZNF280C and p53 suggests that it may be a useful drug target for cancer treatment. Additionally, ZNF280C has been shown to play a role in cell apoptosis, which is a natural process that helps eliminate damaged or dysfunctional cells. Therefore, targeting ZNF280C may be a promising approach for the treatment of various diseases.

Potential Biomarker

ZNF280C has also been identified as a potential biomarker for various diseases. One of its potential biomarkers is the expression of ZNF280C, which can be used as a marker for various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

For example, ZNF280C has been shown to be overexpressed in various neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. This overexpression is associated with increased neuroinflammation and decreased brain function. Therefore, targeting ZNF280C may be a promising approach for the treatment of neurodegenerative diseases.

Another example is the regulation of ZNF280C expression in cancer cells. ZNF280C has been shown to be downregulated in various types of cancer, including breast, lung, and colorectal cancer. This downregulation is associated with increased cancer cell survival and a decreased response to chemotherapy. Therefore, targeting ZNF280C may be a promising approach for the treatment of various types of cancer.

Conclusion

ZNF280C is a unique ZFP that has been identified as a potential drug target and biomarker. Its interaction with the protein p53 and its involvement in various cellular processes make it a promising target for cancer treatment. Additionally, its potential as a biomarker for various diseases, including cancer and neurodegenerative diseases, makes it an attractive candidate for further research.

In conclusion, ZNF280C is a potential drug target and biomarker that may have significant implications for the treatment of various diseases. Further research is needed to fully understand its biology and its potential as a drug and biomarker.

Protein Name: Zinc Finger Protein 280C

Functions: May function as a transcription factor

The "ZNF280C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF280C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF280D | ZNF281 | ZNF282 | ZNF283 | ZNF284 | ZNF285 | ZNF285CP | ZNF286A | ZNF286B | ZNF287 | ZNF292 | ZNF295-AS1 | ZNF296 | ZNF3 | ZNF30 | ZNF300 | ZNF300P1 | ZNF302 | ZNF304 | ZNF311 | ZNF316 | ZNF317 | ZNF318 | ZNF319 | ZNF32 | ZNF32-AS1 | ZNF32-AS2 | ZNF32-AS3 | ZNF320 | ZNF321P | ZNF322 | ZNF322P1 | ZNF324 | ZNF324B | ZNF326 | ZNF329 | ZNF330 | ZNF331 | ZNF333 | ZNF334 | ZNF335 | ZNF337 | ZNF33A | ZNF33B | ZNF33BP1 | ZNF34 | ZNF341 | ZNF341-AS1 | ZNF343 | ZNF345 | ZNF346 | ZNF347 | ZNF35 | ZNF350 | ZNF350-AS1 | ZNF354A | ZNF354B | ZNF354C | ZNF355P | ZNF358 | ZNF362 | ZNF365 | ZNF366 | ZNF367 | ZNF37A | ZNF37BP | ZNF382 | ZNF383 | ZNF384 | ZNF385A | ZNF385B | ZNF385C | ZNF385D | ZNF385D-AS1 | ZNF385D-AS2 | ZNF391 | ZNF394 | ZNF395 | ZNF396 | ZNF397 | ZNF398 | ZNF402P | ZNF404 | ZNF407 | ZNF407-AS1 | ZNF408 | ZNF41 | ZNF410 | ZNF414 | ZNF415 | ZNF416 | ZNF417 | ZNF418 | ZNF419 | ZNF420 | ZNF423 | ZNF425 | ZNF426 | ZNF428 | ZNF429